Reliability of Pupil Response to Acute Pain
2 other identifiers
observational
20
1 country
1
Brief Summary
The purpose of this research study is to test whether researchers can reliably measure the response pupils have when an acute painful stimulus is experienced. Changes in the size of the pupil of the eye can be an indicator of brain activity in a region of the brain that is important for feeling pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2015
CompletedStudy Start
First participant enrolled
August 4, 2015
CompletedFirst Posted
Study publicly available on registry
December 11, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 16, 2025
CompletedResults Posted
Study results publicly available
July 31, 2026
CompletedJuly 31, 2026
April 1, 2026
9.9 years
July 8, 2015
June 9, 2026
July 7, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Percentage of Change in Pupil Diameter
pupil diameter in response to 5 second presentation of noxious heat stimuli
8 weeks
Pain Score on Visit 1
Participants rated their pain intensity during 5 seconds of heating the skin surface to 50 degrees. They used a scale of 0-100, with 0 being no pain at all and 100 being the worst pain imaginable. The heat was applied 5 times over 7.5 minutes and these 6 scores were averaged as their individual score.
Day 1
Pain Score on Visit 2
Participants rated their pain intensity during 5 seconds of heating the skin surface to 50 degrees. They used a scale of 0-100, with 0 being no pain at all and 100 being the worst pain imaginable. The heat was applied 5 times over 7.5 minutes and these 6 scores were averaged as their individual score.
Week 2
Pain Score on Visit 3
Participants rated their pain intensity during 5 seconds of heating the skin surface to 50 degrees. They used a scale of 0-100, with 0 being no pain at all and 100 being the worst pain imaginable. The heat was applied 5 times over 7.5 minutes and these 6 scores were averaged as their individual score.
Month 1
Pain Score on Visit 4
Participants rated their pain intensity during 5 seconds of heating the skin surface to 50 degrees. They used a scale of 0-100, with 0 being no pain at all and 100 being the worst pain imaginable. The heat was applied 5 times over 7.5 minutes and these 6 scores were averaged as their individual score.
Month 2
Study Arms (1)
Osteoarthritis
Study population to include adult men and women with osteoarthritis.
Eligibility Criteria
Individuals with athritis in the knee or hip with moderate average daily pain score
You may qualify if:
- Adult (18-70)
- Pain from hip or knee arthritis of moderate intensity
- American Society of Anesthesiologists physical status 1-3
You may not qualify if:
- Inability to complete study questionnaires
- Pregnancy
- Litigation or workers compensation related to hip or knee pain
- Taking \> 50 mg morphine equivalents/day
- History of Raynaud's disease of the feet
- Psychotic disorder or a recent psychiatric hospitalization
- History of eye surgery or topical eye medications that would would directly affect pupil diameter
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, 27157, United States
Biospecimen
Whole Blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Early termination leading to small numbers of subjects analyzed: technical problems with pupil diameter measurement leading to unreliable data which were not analyzed.
Results Point of Contact
- Title
- Dr. James C. Eisenach
- Organization
- Wake Forest University School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
James C Eisenach, MD
Wake Forest University Health Sciences
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2015
First Posted
December 11, 2015
Study Start
August 4, 2015
Primary Completion
June 16, 2025
Study Completion
June 16, 2025
Last Updated
July 31, 2026
Results First Posted
July 31, 2026
Record last verified: 2026-04